BeiGene

BeiGene is a publicly traded biopharmaceutical company focused on oncology and hematology. The company's stated mission, under the name BeOne Medicines, is to build a leading oncology company by combining scientific research with rapid development timelines to expand patient access to treatments.

The company has a workforce of approximately 12,000 people, including over 1,200 research team members. Its technical domains include solid tumors, protein degradation with CDACs, and antibody drug conjugates. BeiGene has initiated more than 175 clinical trials globally, enrolling over 30,000 patients across more than 45 countries and regions.

Three of BeiGene's internally developed medicines have received regulatory approval in over 75 countries. The company maintains a global presence spanning six continents with more than 45 office locations worldwide.